(Q48903717)

16 February 2018

title

Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit. (English)

1 reference

16 February 2018

main subject

hepatic encephalopathy

1 reference

1 reference

C C van der Rijt

1

1 reference

16 February 2018

R J de Knegt

2

1 reference

16 February 2018

S W Schalm

3

1 reference

16 February 2018

O T Terpstra

4

1 reference

16 February 2018

K Mechelse

5

1 reference

16 February 2018

publication date

1 September 1990

1 reference

16 February 2018

published in

Metabolic Brain Disease

1 reference

16 February 2018

volume

5

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

131-141

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00999840

exact match

0 references

cites work

Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists.

1 reference

12 December 2020

Differentiation of drug-induced rhythmical activities in the rabbit's brain by a benzodiazepine antagonist.

1 reference

12 December 2020

In vivo studies of GABAergic effects in experimental hepatic encephalopathy

1 reference

12 December 2020

Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy

1 reference

12 December 2020

Postsynaptic gamma-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.

1 reference

12 December 2020

The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status

1 reference

12 December 2020

Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

1 reference

12 December 2020

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

1 reference

12 December 2020

Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials

1 reference

12 December 2020

Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

1 reference

12 December 2020

Objective measurement of hepatic encephalopathy by means of automated EEG analysis

1 reference

12 December 2020

Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure

1 reference

12 December 2020

Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy

1 reference

12 December 2020

Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil

1 reference

12 December 2020

Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat

1 reference

12 December 2020

Benzodiazepine receptor ligands with positive and negative efficacy

1 reference

12 December 2020

Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788)

1 reference

12 December 2020

Improvement of hepatic encephalopathy treated with flumazenil

1 reference

12 December 2020

Renin-angiotensin system, blood pressure homeostasis and renal function in galactosamine-induced fulminant hepatic failure in the guinea pig.

1 reference

12 December 2020

Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock

1 reference

12 December 2020

Glutamate, GABA, and CNS disease: A review

1 reference

12 December 2020

gamma-Aminobutyric acid plasma levels and brain binding in Eck fistula dogs.

1 reference

12 December 2020

Flumazenil and hepatic encephalopathy

1 reference

12 December 2020

A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt

1 reference

12 December 2020

Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity

1 reference

12 December 2020

Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study

1 reference

12 December 2020

Ro 15-1788 and hepatic failure

1 reference

12 December 2020

Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid

1 reference

12 December 2020

A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding

1 reference

12 December 2020

Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors

1 reference

12 December 2020

Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00999840

1 reference

16 February 2018

1 reference

16 February 2018